Simran Preet Selected Research

Therapeutics

1/2023	Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics.
11/2022	Organogel mediated co-delivery of nisin and 5-fluorouracil: a synergistic approach against skin cancer.
5/2022	Anticancer therapeutic potential of 5-fluorouracil and nisin co-loaded chitosan coated silver nanoparticles against murine skin cancer.
3/2022	Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeutics.
1/2020	Anticancer potential of human intestinal defensin 5 against 1, 2-dimethylhydrazine dihydrochloride induced colon cancer: A therapeutic approach.
11/2015	Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis--a possible adjunct therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simran Preet Research Topics

Disease

8	Neoplasms (Cancer) 02/2024 - 11/2015
4	Skin Neoplasms (Skin Cancer) 11/2022 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 02/2024 - 01/2020
2	Carcinogenesis 01/2021 - 11/2015
2	Infections 12/2017 - 05/2010
2	Salmonella Infections (Salmonellosis) 09/2011 - 05/2010
1	Metabolic Diseases (Metabolic Disease) 01/2023
1	COVID-19 03/2022
1	Carcinoma (Carcinomatosis) 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Burns 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Aberrant Crypt Foci 01/2020
1	Body Weight (Weight, Body) 12/2019
1	Necrosis 07/2014
1	Amebiasis (Amoebiasis) 12/2011

Drug/Important Bio-Agent (IBA)

5	Peptides (Polypeptides)IBA 01/2023 - 01/2020
5	NisinIBA 11/2022 - 11/2015
4	Fluorouracil (Carac)FDA LinkGeneric 02/2024 - 12/2019
4	cryptdin 2IBA 12/2017 - 05/2010
3	Antimicrobial PeptidesIBA 01/2021 - 05/2010
2	cryptdinIBA 02/2024 - 01/2020
2	DefensinsIBA 02/2024 - 01/2020
2	AntioxidantsIBA 05/2022 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021 - 11/2015
1	MucinsIBA 02/2024
1	SilverIBA 05/2022
1	Oxidants (Oxidizing Agents)IBA 05/2022
1	ChitosanIBA 05/2022
1	MicellesIBA 04/2021
1	Excipients (Suspending Agents)IBA 04/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2021
1	carboxypolymethyleneIBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	CytokinesIBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2021
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2020
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 01/2020
1	Bacteriocins (Lantibiotics)IBA 12/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2017
1	EnzymesIBA 07/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014
1	Metronidazole (Metric)FDA LinkGeneric 12/2011
1	Ampicillin (Omnipen)FDA LinkGeneric 09/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2010

Therapy/Procedure

6	Therapeutics 01/2023 - 11/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 12/2019